HCLSoftware bets on India's AI push, sovereign cloud systems
Wed, Nov 27, 2024 1:09 PM

HCLSoftware bets on India's AI push, sovereign cloud systems

A Flip by Avya Verma
Get it on Google Play
Information technology (IT) services major HCLTech’s software business is betting big on attracting new contracts in India. It is driven by the government’s artificial intelligence (AI) mission and a focus on setting up sovereign systems such as industry-specific cloud environments among a slew of many other major initiatives, a top executive of the country’s third-largest software exporter.

More great flips

SF Holding delivers a lacklustre trading debut in Hong Kong

SF Holding delivers a lacklustre trading debut in Hong Kong

SF Holding, China's largest courier deliverer often regarded as the nation's equivalent to FedEx, delivered a flat trading debut in Hong Kong amid tepid sentiment, a precursor to a busy week of stock debuts that will add several billion Hong Kong dollars to this year's listing proceeds. Trading under the 6936 code, SF shares rose by as much as 1.2 per cent to an intraday high of HK$35.50.

Open Flip
Petronet LNG Standalone September 2024 Net Sales at Rs 13,021.82 crore

Petronet LNG Standalone September 2024 Net Sales at Rs 13,021.82 crore

Petronet LNG's quarterly net sales rose 3.91% to Rs 13,021.82 crore, with a 3.61% increase in net profit to Rs 847.62 crore, driven by higher sales and stable margins, with the company's EPS increasing to Rs 5.65 from Rs 5.45. Petronet LNG's shares closed at 328.90, with 9% returns over the last 6 months and 67.51% over the last 12 months.

Open Flip
Shilpa Medicare’s JV Oncosol & partner Shorla Oncology gets US FDA approval

Shilpa Medicare’s JV Oncosol & partner Shorla Oncology gets US FDA approval

Shilpa Medicare's Joint Venture Oncosol, along with its partner Shorla Oncology, on Wednesday announced that the US FDA has approved IMKELDI (imatinib oral solution). IMKELDI is the first oral liquid form of imatinib used to treat certain forms of leukemia and other cancers. IMKELDI is an advanced liquid formulation of imatinib designed to provide dosing accuracy.

Open Flip

Join our Smart Investment Community

More than 2 Million users are using FlipItMoney to stay updated about the business and finance world! Join FlipItMoney now and take smart investment decisions!
Icon